Physician profile
Eugene G Chio
NPI 1790846012
$38,584.86
in general payments reported to CMS, 2019-2025
6 companies · $569 in 2025
The $569 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,342 · 2020: $112 · 2021: $16K · 2022: $2,880 · 2023: $7,742 · 2024: $10K · 2025: $569.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $10K · Education: $5,463 · Food and Beverage: $1,805 · Travel and Lodging: $1,295.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $10,162.50 |
| Education | $5,462.50 |
| Food and Beverage | $1,804.97 |
| Travel and Lodging | $1,295.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $38,317.41 | 2019-2025 | Inspire |
| Grace Medical, INC. | $137.56 | 2025 | |
| Optinose US, INC. | $79.91 | 2024-2025 | |
| Astrazeneca Pharmaceuticals LP | $21.71 | 2025 | Tezspire |
| Stryker Corporation | $14.71 | 2025 | Audion Et Dilation System |
| Paratek Pharmaceuticals, INC. | $13.56 | 2025 | Xhance |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eugene Chio listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.